Page 15 - Mark Denison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Matt Miller Michael S. Diamond, MD, PhD, (left) and Sean Whelan, PhD, collaborate on research into the virus that causes COVID-19. Early in the pandemic, they cooperated to build a laboratory where the novel coronavirus could be studied. A new episode of our podcast, “Show Me the Science,” has been posted. At present, these podcast episodes are highlighting research and patient care on the Washington University Medical Campus as our scientists and clinicians confront the COVID-19 pandemic. Even before the first case of COVID-19 was reported in the United States, Michael S. Diamond, MD, Ph...

Renowned immunologist and oncologist Carl June receives $1 million Sanford Lorraine Cross Award Carl June, M.D., professor in immunotherapy in the Perelman School of Medicine at the University of Pennsylvania, has received the nation's largest award in medicine given by a health system. News provided by Share this article Share this article SIOUX FALLS, S.D., April 14, 2021 /PRNewswire/ -- Sanford Health, the largest provider of rural healthcare in the country, today announced Carl June, M.D. as the winner of the biennial Sanford Lorraine Cross Award which honors life-changing breakthroughs a...

The Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine in the Perelman School of Medicine and director of the Center for Cellular Immunotherapies at Penn’s Abramson Cancer Center received the award for his work in developing chimeric antigen receptor (CAR) T cell therapy.

Sanford Health $1M award given to Dr. Carl June for cancer-killing therapy Sanford Health gave its $1 million 2021 Sanford Lorraine Cross Award to Dr. Carl June, the health system announced Tuesday, April 13. June and colleagues who developed a therapy that finds and kills leukemia cancer cells.  11:54 am, Apr. 14, 2021 × Sanford Health President and CEO Bill Gassen, center, presents Dr. Carl June with the $1 million Sanford Lorraine Award for June's development of a therapy that kills leukemia cancer cells, as Executive Vice President Micah Aberson looks on, Tuesday, ...

Science's COVID-19 reporting is supported by the Heising-Simons Foundation ILLUSTRATION: STEPHAN SCHMITZ/FOLIO ART In March 2020, as the scope of the COVID-19 pandemic was coming into view, Jen Nwankwo and colleagues turned a pair of artificial intelligence (AI) tools against SARS-CoV-2. One newly developed AI program, called SUEDE, digitally screens all known druglike compounds for likely activity against biomolecules thought to be involved in disease. The other, BAGEL, predicts how to build inhibitors to known targets. The two programs searched for compounds able to block human enzymes that...